Kathleen R Ruddiman, Jessica K Bartfield, Irl B Hirsch
{"title":"Understanding the Increasing Prevalence of Obesity in Patients With Type 1 Diabetes: Strategies for Improving Clinical Care.","authors":"Kathleen R Ruddiman, Jessica K Bartfield, Irl B Hirsch","doi":"10.1002/oby.70033","DOIUrl":null,"url":null,"abstract":"<p><p>The presence of excess weight is no longer a distinguishing feature between patients with type 1 diabetes (T1D) and those with type 2 diabetes (T2D). Obesity treatment in patients with T2D improves glycemic control and reduces or even eliminates medication burden. Robust evidence and clear guidelines exist to support and direct effective weight management in patients with T2DM. Now, however, rates of obesity in patients with T1D rival those found in the general population, yet little is known about the efficacy, safety, and unique considerations of obesity treatment (lifestyle modifications, pharmacology, and surgery) in this population. This review tackles these topics and the gaps in evidence and clinical care.</p>","PeriodicalId":94163,"journal":{"name":"Obesity (Silver Spring, Md.)","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obesity (Silver Spring, Md.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/oby.70033","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The presence of excess weight is no longer a distinguishing feature between patients with type 1 diabetes (T1D) and those with type 2 diabetes (T2D). Obesity treatment in patients with T2D improves glycemic control and reduces or even eliminates medication burden. Robust evidence and clear guidelines exist to support and direct effective weight management in patients with T2DM. Now, however, rates of obesity in patients with T1D rival those found in the general population, yet little is known about the efficacy, safety, and unique considerations of obesity treatment (lifestyle modifications, pharmacology, and surgery) in this population. This review tackles these topics and the gaps in evidence and clinical care.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
